Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats

Journal of Veterinary Pharmacology and Therapeutics - Tập 35 Số 2 - Trang 121-131 - 2012
Teresa L. Leavens1, Lisa A. Tell, Kristin A. Clothier, Ronald W. Griffith, Ronald E. Baynes, Jim E. Riviere
1Center for Chemical Toxicology Research and Pharmacokinetics, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27709, USA. [email protected]

Tóm tắt

Leavens, T. L., Tell, L. A., Clothier, K. A., Griffith, R. W., Baynes, R. E., Riviere, J. E. Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats. J. vet. Pharmacol. Therap. 35, 121–131.Physiologically based pharmacokinetic (PBPK) models, which incorporate species‐ and chemical‐specific parameters, could be useful tools for extrapolating withdrawal times for drugs across species and doses. The objective of this research was to develop a PBPK model for goats to simulate the pharmacokinetics of tulathromycin, a macrolide antibiotic effective for treating respiratory infections. Model compartments included plasma, lung, liver, muscle, adipose tissue, kidney, and remaining poorly and richly perfused tissues. Tulathromycin was assumed to be 50% protein bound in plasma with first‐order clearance. Literature values were compiled for physiological parameters, partition coefficients were estimated from tissue:plasma ratios of AUC, and the remaining model parameters were estimated by comparison against the experimental data. Three separate model structures were compared with plasma and tissue concentrations of tulathromycin in market age goats administered 2.5 mg/kg tulathromycin subcutaneously. The best simulation was achieved with a diffusion‐limited PBPK model and absorption from a two‐compartment injection site, which allowed for low persistent concentrations at the injection site and slower depletion in the tissues than the plasma as observed with the experimental data. The model with age‐appropriate physiological parameters also predicted plasma concentrations in juvenile goats administered tulathromycin subcutaneously. The developed model and compilation of physiological parameters for goats provide initial tools that can be used as a basis for predicting withdrawal times of drugs in this minor species.

Từ khóa


Tài liệu tham khảo

10.1016/S1286-4579(00)01262-4

APHIS(2004)The Goat Industry: Structure Concentration Demand and Growth. APHIS Electronic Report. [http://www.aphis.usda.gov/animal_health/emergingissues/downloads/goatreport090805.pdf] last accessed 9/2010.

Arguello A., 2007, The influence of artificial rearing and live weight at slaughter on kid carcass characteristics, Journal of Animal and Veterinary Advances, 6, 20

10.1111/j.1365-2885.2004.00586.x

10.2460/javma.229.8.1279

Bischoff K.B., 1971, Principles and applications of models for drug distribution, Federation Proceedings, 30, 702

Brocklebank J.R., 1997, An oxytetracycline residue depletion study to assess the physiologically based pharmokinetic (PBPK) model in farmed Atlantic salmon, The Canadian Veterinary Journal. La Revue Veterinaire Canadienne, 38, 645

Brogden K.A., 1998, Pasteurella haemolytica complicated respiratory infections in sheep and goats, Veterinary Research, 29, 233

10.1177/074823379701300401

10.1128/AAC.01355-05

10.1016/j.yrtph.2008.05.003

10.1016/j.rvsc.2008.07.003

Clothier K.A., Pharmacokinetics of tulathromycin after single and multiple subcutaneous injections in domestic goats (Capra aegagrus hircus), Journal of Veterinary Pharmacology and Therapeutics

Clothier K.A., Tulathromycin assay validation and tissue residues after single and multiple subcutaneous injections in domestic goats (Capra aegagrus hircus), Journal of Veterinary Pharmacology and Therapeutics

10.1111/j.1365-2885.2009.01073.x

10.1046/j.1365-2885.2003.00451.x

Evans N.A., 2005, Tulathromycin: An overview of a new triamilide antibiotic for livestock respiratory disease, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 83

FDA. (1994)Animal medicinal drug use clarification act. 21 CFR 530 1–41.

FDA. (2005)Tulathromycin Freedom of Information Summary Original New Animal Drug Application NADA 141‐244 [http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm118064.pdf] last accessed 9/2010.

10.1021/jf0351624

10.1007/BF01066322

10.1016/S0273-2300(03)00047-3

Godinho K.S., 2005, Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 122

10.1136/vr.158.13.433

10.1016/j.smallrumres.2006.05.001

Kilgore W.R., 2005, Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 136

10.1002/cbdv.200900150

10.1080/02652030802669170

Mahgoub O., 1997, Meat production from the omani dhofari goat 1. live weight growth and body composition, International Journal of Animal Science, 12, 12

10.1016/0921-4488(95)00762-8

10.1017/S0021859698005887

10.1016/S0921-4488(97)00055-2

10.1016/j.meatsci.2003.12.011

McKelvie J., 2005, Evaluation of tulathromycin for the treatment of pneumonia following experimental infection of swine with mycoplasma hyopneumoniae, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 197

10.2527/jas.2009-1835

Nowakowski M.A., 2004, Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 5, 60

Nutsch R.G., 2005, Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 214

Nutsch R.G., 2005, Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 167

10.1016/0921-4488(95)00730-X

Rooney K.A., 2005, Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease, Veterinary Therapeutics: Research in Applied Veterinary Medicine, 6, 154

10.1177/104063870501700505

10.2527/jas.2008-1291

10.1111/j.1365-2885.2007.00837.x

10.2460/javma.2004.224.520

10.1007/s11259-008-9178-z

10.1016/j.rvsc.2010.06.025

10.1046/j.1439-0450.2001.00463.x

Thông tin
Thông tin xuất bản

Journal of Veterinary Pharmacology and Therapeutics

Tập 35 Số 2

121-131

Thông tin tác giả